Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
作者： Elvire Gouze , Stéphanie Garcia
DOI:
关键词:
摘要: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. also methods of using sFGFR3 polypeptides to treat skeletal retardation disorders, such as achondroplasia.
lens.org 参考文章(85)
Sara Blumenstein, Irina Chumakov, Eran Rom, Avner Yayon, N-terminal fgf variants having increased receptor selectivity and uses thereof ,(2007)
Neelam Jaiswal, Douglas W. Axelrod, Jonathan S. Cook, Darren Ji, Lawrence Mertz, Adam Houghton, Treatment of bone disorders by modulation of fgfr3 ,(2001)
Anna Lasorella, Raul Rabadan, Antonio Iavarone, Fusion proteins and methods thereof ,(2013)
Taruna Arora, Betty Chan Li, Kalyani Mondal, Wenyan Shen, Yu Chen, Hugo Matern, Binding proteins and methods of use thereof ,(2015)
Diane Hollenbaugh, Minmin Qin, Justin Wong, Ernestine Lee, Kevin Hestir, Ali Sadra, Elizabeth Bosch, Hongbing Zhang, Stephen Doberstein, Lewis T. Williams, Ge Wu, FGFR3-IIIc fusion proteins ,(2010)
Kazuwa Nakao, Therapeutic agents for achondroplasia ,(2002)
Janine Powers, W. Michael Kavanaugh, Robert Dean, Thomas Brennan, Hair growth methods using FGFR3 extracellular domains ,(2010)
William A. Horton, Gregory P. Lunstrum, Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism. Reviews in Endocrine & Metabolic Disorders. ,vol. 3, pp. 381- 385 ,(2002) , 10.1023/A:1020914026829
M. K. Webster, D. J. Donoghue, Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. The EMBO Journal. ,vol. 15, pp. 520- 527 ,(1996) , 10.1002/J.1460-2075.1996.TB00384.X
Christian Wiesmann, Crystal structures and methods using same ,(2012)